Ibritumomab

Drug Name: Ibritumomab tiuxetan

Drug Class: It is a targeted therapy drug

Available under the brand name: Zevalin

What Is It Prescribed For? 

• Non-Hodgkin’s lymphoma (a condition where cancer affects the lymph system which produces immune cells).
• Follicular B-cell non-Hodgkin’s lymphoma

How Is It Given?

It is given as an infusion into a vein over 10 minutes. Firstly, Rituximab is given and then the first dose of Ibritumomab is given within 4 hours. Imaging tests are done to see how it has spread and shown its actions. If expected results are shown, then the next doses will be given for 7 to 9 days.

What Are Common Side Effects?

You may face some of these side effects:

• Infusion-related reactions like fever, chills, redness, tiredness, headache, shortness of breath, nausea, and decreased blood pressure
• Low blood count
• Increased susceptibility to infections
• Loss of appetite
• Muscle or joint pain
• Cough
• Dizziness
• Nausea
• Diarrhea

Your doctor can prescribe medication to control these side effects. Ibritumomab also causes other side effects. If you face any unusual or serious problems, inform your doctor immediately.

Who Should Avoid Taking This Drug?

None

How Much Does This Drug Cost?

Currently, it is not available in India. But it can be imported upon request and cost varies depending on multiple factors.